Validating a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 4, 2013, Pages 953-958

  Cheng, Skye Hung Chun ^a,b   Tsai, Stella Y ^a,b   Yu, Ben Long ^a   Horng, Cheng Fang ^a   Chen, Chii Ming ^a   Jian, James J ^a,b   Chu, Nan Min ^a   Tsou, Mei Hua ^a   Liu, Mei Ching ^a   Huang, Andrew T ^a,b   Prosnitz, Leonard R ^b  

^a KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; INTERMEDIATE RISKS; LOCOREGIONAL CONTROL RATE; LOCOREGIONAL RECURRENCE; LYMPHOVASCULAR INVASIONS; METHODS AND MATERIALS; POSTMASTECTOMY RADIATION THERAPIES; RADICAL MASTECTOMY;

DISEASES; PATIENT MONITORING;

PATIENT TREATMENT;

ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER INVASION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; FEMALE; HUMAN; LOCOREGIONAL RECURRENCE RISK SCORING SYSTEM; LYMPH NODE; MAJOR CLINICAL STUDY; MASTECTOMY; POSTMASTECTOMY RADIATION THERAPY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; VALIDATION PROCESS;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ESTROGEN; RISK ASSESSMENT; TUMOR BURDEN; YOUNG ADULT;

EID: 84875220033     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.08.042     Document Type: Article

References (20)

1. H.M. Nielsen, M. Overgaard, and C. Grau Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiation therapy in addition to adjuvant systemic therapy: Long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies J Clin Oncol 24 2006 2268 2275
2. L.J. Pierce The use of radiotherapy after mastectomy: a review of the literature J Clin Oncol 23 2005 1706 1717
3. M. Clarke, R. Collins, and S. Darby Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials Lancet 366 2005 2087 2106
4. S. Darby, P. McGale, and C. Correa Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials Lancet 378 2011 1707 1716
5. M. Kyndi, M. Overgaard, and H.M. Nielsen High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c Radiother Oncol 90 2009 74 79
6. A. Recht, S.B. Edge, and L.J. Solin Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology J Clin Oncol 19 2001 1539 1569
7. I.A. Olivotto, P.T. Truong, and B. Chua Postmastectomy radiation therapy: Who needs it? J Clin Oncol 22 2004 4237 4239
8. A. Recht, and S.B. Edge Evidence-based indications for postmastectomy irradiation Surg Clin North Am 83 2003 995 1013
9. L.B. Marks, J. Zeng, and L.R. Prosnitz One to three versus four or more positive nodes and postmastectomy radiotherapy: Time to end the debate J Clin Oncol 26 2008 2075 2077
10. M.E. Taylor, B.G. Haffty, and R. Rabinovitch ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast Int J Radiat Oncol Biol Phys 73 2009 997 1002
11. W.A. Woodward, E.A. Strom, and S.L. Tucker Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation Int J Radiat Oncol Biol Phys 57 2003 336 344
12. P.T. Truong, I.A. Olivotto, and H.A. Kader Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy Int J Radiat Oncol Biol Phys 61 2005 1337 1347
13. G. Gruber, B.F. Cole, and M. Castiglione-Gertsch Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer Ann Oncol 19 2008 1393 1401
14. S.H. Cheng, C.F. Horng, and J.L. Clarke Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients Int J Radiat Oncol Biol Phys 64 2006 1401 1409
15. P.P. Rosen Tumor emboli in intramammary lymphatics in breast carcinoma: Pathologic criteria for diagnosis and clinical significance Pathol Annu 18 1983 215 232
16. Breast cancer, NCCN guidelines Available at http://www.nccn.org/ professionals/physician-gls/pdf/breast.pdf 2011 Accessed June 27, 2011
17. T.K. Poonacha, and R.S. Go Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines J Clin Oncol 29 2011 186 191
18. M. Gnant, N. Harbeck, and C. Thomssen St. Gallen 2011: Summary of the Consensus Discussion Breast Care (Basel) 6 2011 136 141
19. B.G. Haffty, and S. Goyal Molecular subtyping of early-stage breast cancer: Implications for radiation therapy Int J Radiat Oncol Biol Phys 77 2010 1293 1295
20. E.P. Mamounas, G. Tang, and B. Fisher Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node -negative estrogen receptor- positive breast cancer: Results from NSABP B-14 and NSABP B- 20 J Clin Oncol 28 2010 1677 1683